Neurotropic Effects of Cortexin on Models of Mental and Physical Developmental Delay
Open Access
- 2 April 2025
- journal article
- Published by MDPI AG in Biomedicines
- Vol. 13 (4)
Abstract
Objective: To evaluate the efficacy of the neurotropic action of cortexin in models of mental and physical developmental delays in rat offspring. Methods: The neurotropic properties of bovine brain cortex polypeptides were studied using two models of mental and physical developmental delays in rats: toxic CNS damage (oral administration of ethanol during the last week of pregnancy) and neonatal trauma (ischemia-hypoxia). The drug was administered intramuscularly or rectally as suppositories for 20 days. Treatment efficacy was evaluated using the mNSS scale, open field, rotarod, and adhesive removal tests. A histological examination of the brain was subsequently performed. In a separate series of experiments in mice, the concentration of the test drug cortexin and the reference drug cerebrolysin was determined in blood and brain tissue samples using radioactive iodine (Na125I) labeling of these preparations. Results: Modeling developmental delay in rat offspring (due to the toxic effect of ethanol in late pregnancy or neonatal trauma) led to pronounced neurological deficits, manifested by decreased motor activity, and sensorimotor, and coordination disorders. Administration of cortexin in all forms reduced the severity of neurological deficits as measured by mNSS scores, improved motor activity in the Open Field test, enhanced performance in the Adhesive Removal and Rotarod tests, and decreased structural changes in brain tissues. Histological examination revealed reduced neuronal damage in multiple cortical regions, with a significant increase in normal, unchanged neurons compared to placebo groups. Comparison of the blood concentrations of labeled Na125I cortexin depending on the type of administration showed similar distribution profiles in brain tissues, primarily dependent on its blood concentration, which was influenced by the route of administration. Conclusions: The results indicate that brain polypeptides (cortexin), administered either intramuscularly or rectally, can reach the systemic circulation and cross the blood-brain barrier, as demonstrated by our distribution studies using radiolabeled preparations. These polypeptides exert comparable neurotropic effects in models of mental and physical developmental delays in offspring caused by neonatal trauma or the toxic effect of ethanol in late pregnancy in rats.Keywords
Funding Information
- Pharm-Holding CJSC (152902)
This publication has 22 references indexed in Scilit:
- Neuroprotective effects of oxymatrine on hypoxic–ischemic brain damage in neonatal rats by activating the Wnt/β-catenin pathwayBiomedicine & Pharmacotherapy, 2023
- Animal models for neonatal brain injury induced by hypoxic ischemic conditions in rodentsExperimental Neurology, 2020
- Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trialsNeurological Sciences, 2017
- Rectal route in the 21st Century to treat childrenAdvanced Drug Delivery Reviews, 2014
- Ethanol exposure during late gestation and nursing in the rat: Effects upon maternal care, ethanol metabolism and infantile milk intakePharmacology Biochemistry and Behavior, 2008
- Neuroprotection for ischemic stroke: Past, present and futureNeuropharmacology, 2008
- Comparison of incremental and accelerating protocols of the rotarod test for the assessment of motor deficits in the 6-OHDA modelJournal of Neuroscience Methods, 2006
- The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a reviewEuropean Journal of Pharmacology, 2003
- The influence of immaturity on hypoxic‐ischemic brain damage in the ratAnnals of Neurology, 1981
- A low cost gamma-vial for counting 125I with a liquid scintillation counterClinica Chimica Acta, 1976